Connection

Mohamad Mohty to Antineoplastic Agents

This is a "connection" page, showing publications Mohamad Mohty has written about Antineoplastic Agents.
Connection Strength

0.180
  1. Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Expert Rev Clin Pharmacol. 2018 Feb; 11(2):113-124.
    View in: PubMed
    Score: 0.057
  2. Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma. Blood. 2018 01 18; 131(3):301-310.
    View in: PubMed
    Score: 0.056
  3. Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia. Cancer. 2017 Aug 01; 123(15):2867-2874.
    View in: PubMed
    Score: 0.054
  4. Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT. Cancer. 2017 06 01; 123(11):1965-1970.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.